Cargando…

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer

Bladder cancer is a heterogeneous disease with outcome difficult to predict, and novel predictive biomarkers are needed. PCDH7, a member of protocadherins family, functions as tumor suppressor in several human cancers. The human PCDH7 gene is localized in chromosome 4p15, which is often inactivated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ying-Li, Wang, Yan-Ling, Fu, Xing-Li, Li, Wen-Ping, Wang, Yu-Hao, Ma, Jian-Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053733/ https://www.ncbi.nlm.nih.gov/pubmed/27070091 http://dx.doi.org/10.18632/oncotarget.8635

Ejemplares similares

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2014)

Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
por: Deng, Qiu-Kui, et al.
Publicado: (2016)

Adjuvant Treatment for Protocadherin 19 (PCDH19) Syndrome
por: Moncayo, Juan A, et al.
Publicado: (2022)

Biallelic mutation of Protocadherin-21 (PCDH21) causes retinal degeneration in humans
por: Henderson, Robert H., et al.
Publicado: (2010)

Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy
por: Lin, Ying-Li, et al.
Publicado: (2015)

Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma
por: Yu, Hong, et al.
Publicado: (2020)

The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome
por: Miyake, Kunio, et al.
Publicado: (2011)

Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2017)

Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer
por: Lin, Ying-Li, et al.
Publicado: (2017)

Understanding Protein Protocadherin-19 (PCDH19) Syndrome: A Literature Review of the Pathophysiology
por: Moncayo, Juan A, et al.
Publicado: (2022)

Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2014)

The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer
por: Zhang, Shitong, et al.
Publicado: (2021)

PCDH7 as the key gene related to the co-occurrence of sarcopenia and osteoporosis
por: Liu, Mingchong, et al.
Publicado: (2023)

PCDH7 Inhibits the Formation of Homotypic Cell-in-Cell Structure
por: Wang, Chenxi, et al.
Publicado: (2020)

The protocadherin 11X/Y (PCDH11X/Y) gene pair as determinant of cerebral asymmetry in modern Homo sapiens
por: Priddle, Thomas H, et al.
Publicado: (2013)

The Clustered Gamma Protocadherin Pcdhγc4 Isoform Regulates Cortical Interneuron Programmed Cell Death in the Mouse Cortex
por: Leon, Walter R Mancia, et al.
Publicado: (2023)

p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
por: Chen, Liuxi, et al.
Publicado: (2019)

Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα)
por: Pham, Duyen H., et al.
Publicado: (2017)

The roles of protocadherin-7 in colorectal cancer cells on cell proliferation and its chemoresistance
por: Zheng, Zhibao, et al.
Publicado: (2023)

Promoter Methylation of Protocadherin8 is an Independent Prognostic Factor for Biochemical Recurrence of Early-Stage Prostate Cancer
por: Niu, Wen-Bin, et al.
Publicado: (2014)

Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer
por: Li, Xinxin, et al.
Publicado: (2023)

Dopey2 and Pcdh7 orchestrate the development of embryonic neural stem cells/ progenitors in zebrafish
por: Xiao, Yue, et al.
Publicado: (2023)

Exploration of Prognostic Biomarkers of Muscle-Invasive Bladder Cancer (MIBC) by Bioinformatics
por: Xu, Xianglai, et al.
Publicado: (2021)

Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation
por: Kim, Hyunsoo, et al.
Publicado: (2020)

PCDH7 interacts with GluN1 and regulates dendritic spine morphology and synaptic function
por: Wang, Yuanyuan, et al.
Publicado: (2020)

Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer
por: Li, Haimeng, et al.
Publicado: (2021)

PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy
por: Du, Xingyi, et al.
Publicado: (2023)

Identification of prognostic biomarkers associated with stromal cell infiltration in muscle‐invasive bladder cancer by bioinformatics analyses
por: Li, Pan, et al.
Publicado: (2020)

The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer
por: Chen, Yuhao, et al.
Publicado: (2021)

Sequencing and comparative analysis of fugu protocadherin clusters reveal diversity of protocadherin genes among teleosts
por: Yu, Wei-Ping, et al.
Publicado: (2007)

Integrative analysis illustrates the role of PCDH7 in lung cancer development, cisplatin resistance, and immunotherapy resistance: an underlying target
por: Li, Huakang, et al.
Publicado: (2023)

Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer
por: Liu, Wentao, et al.
Publicado: (2018)

PCDH10 Interacts With hTERT and Negatively Regulates Telomerase Activity
por: Zhou, Li-Na, et al.
Publicado: (2015)

Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer
por: Azuma, Takeshi, et al.
Publicado: (2020)

Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy
por: Shibata, Mami, et al.
Publicado: (2020)

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
por: El Demery, Mounira, et al.
Publicado: (2014)

Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2015)

Recurrence-Associated Long Non-coding RNA LNAPPCC Facilitates Colon Cancer Progression via Forming a Positive Feedback Loop with PCDH7
por: Li, Ting, et al.
Publicado: (2020)

Expression of protocadherin gamma in skeletal muscle tissue is associated with age and muscle weakness
por: Hangelbroek, Roland W. J., et al.
Publicado: (2016)

An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese
por: Wang, Yongqiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ip126m50phm442bsg6ukccgcof